Manufacturer record
Medistark Biotech Pvt. Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Medistark Biotech Pvt. Ltd were declared Not of Standard Quality between January 2025 and June 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
2 records linked to Medistark Biotech Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Pantoprazole Sodium Gastro Resistant Tablets IP 40mg (Panzo 40) | MP-240840Mfg 2024-10 · Exp 2026-09 | For the received sample, label is mentioned as ?Approved colour used?Labelling | State Lab PuducherryState lab | Jun 2025 |
| Metoprolol Succinate Extended Release & Telmisartan Tablets (Leaftel Beta ? 25) | MP - 231584Mfg 2024-03 · Exp 2026-02 | The label of the container in the drug is mentioned as 'Approved colour used' but the common name of the permitted colour used in the formulation as prescribed under rule 127 (2) of the drug rule was not mentioned. - MisbrandedMisbranded | State Lab PuducherryState lab | Jan 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.